Clinical trial
Dose-escalating Safety Study in Subjects on Stable Statin Therapy
NCT00231569 · Kastle Therapeutics, LLC, Industry · Completed
Key facts
| NCT number | NCT00231569 |
|---|---|
| Title | Dose-escalating Safety Study in Subjects on Stable Statin Therapy |
| Official title | A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Pharmacodynamics of ISIS 301012 in Hypercholesterolemic Subjects on Stable Statin Therapy |
| Lead sponsor | Kastle Therapeutics, LLC, Industry |
| Collaborators | Ionis Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | ISIS 301012 or Placebo |
| Enrollment | 74 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Oct 4, 2005 |
| Last update posted | Aug 3, 2016 |
| Countries | Netherlands, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: